Shenzhen Yifeng Investment Management Enterprise Limited Partnership

Shenzhen EFUNG Investment Management Enterprise is an institution that invests in professional biomedical industries.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Shenzhen Yifeng Investment Management Enterprise Limited Partnership Information

Geographic Data

Shenzhen Yifeng Investment Management Enterprise Limited Partnership headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China&s;s earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won &s;The Most Pioneering VC Institution” &s;The Most Dynamic Pharmaceutical VC Institution in China&s; and &s;The Top Ten VC Institutions in Shenzhen&s;. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
6/2018 Chipscreen Venture Round -
1/2022 West Lake Omi Seed Round -
5/2010 Rainjet Series A 1.5M
7/2019 TriArm Therapeutics Series A 0
4/2020 SiBionics Series B 28.4M
6/2018 Centrexion Venture Round -
12/2021 BioInno Series A -
3/2022 CellOrigin Biotech Venture Round 0
1/2023 JGene Biotechnology Angel Round -
7/2012 UNIHZ TECHNOLOGY Angel Round 469.6k
11/2020 Biostar Technologies Series E 890M
3/2021 Gensciences Series B -
1/2022 Cloudbreak Therapeutics Series C 0
2/2023 Turno Series A 0
8/2015 Ascentage Pharma Series A 15.5M
12/2022 Maijing Gene Series C -
11/2021 JGene Biotechnology Angel Round -
1/2022 Atom Bioscience &a; Pharmaceutical Series C 45M
1/2018 KBP Biosciences Series A 0
12/2021 Kind Pharmaceutical Series B 50M
3/2020 OBiO Technology Series B 15M
3/2020 Harbour Biomed Series B 75M
6/2018 Frontier Biotechnologies Venture Round -
6/2018 Resverlogix Post-IPO Equity 10.4M
6/2018 Lifotronic Venture Round -
11/2022 Trinomab Venture Round 104.7M
7/2020 OBiO Technology Series C 28.5M
12/2020 Raynovent Series B 42.8M
12/2021 XuanZhu Pharma Series B 0
7/2020 InnerMedical Series B -
12/2021 CirCode Seed Round 20M
7/2019 Zhongyianke Biotech Series A 36M
12/2018 Tactiva Therapeutics Series A 35M
9/2020 Jifu Medical Series C 0
10/2019 WeMed Series C -
6/2018 Aridis Pharmaceuticals Venture Round -
10/2019 Elicio Therapeutics Series B 33M
1/2023 IASO Biotherapeutics Series C 73.8M
1/2023 Raynovent Series C 53.8M
5/2022 JSD Series A -
10/2020 3D Medicines Venture Round 0
11/2012 Castdservo Angel Round 481.6k
2/2022 JGene Biotechnology Seed Round -
5/2022 JSD Series A -
3/2022 CellOrigin Biotech Venture Round 0
1/2022 West Lake Omi Seed Round -
1/2022 Atom Bioscience &a; Pharmaceutical Series C 0
1/2022 Cloudbreak Therapeutics Series C 0
12/2021 XuanZhu Pharma Series B 0
12/2021 Kind Pharmaceutical Series B 0
12/2021 BioInno Series A -
12/2021 CirCode Seed Round 0
11/2021 JGene Biotechnology Angel Round -

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research